Lineage Cell Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.About LCTX
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.
LCTX Key Statistics
Stock Snapshot
With a market cap of 388.58M, Lineage Cell Therapeutics(LCTX) trades at $1.58. The stock has a price-to-earnings ratio of -5.64.
On 2026-04-03, Lineage Cell Therapeutics(LCTX) stock moved within a range of $1.55 to $1.61. With shares now at $1.58, the stock is trading +2.3% above its intraday low and -1.6% below the session's peak.
Trading volume for Lineage Cell Therapeutics(LCTX) stock has reached 581.85K, versus its average volume of 1.08M.
The stock's 52-week range extends from a low of $0.37 to a high of $2.09.
The stock's 52-week range extends from a low of $0.37 to a high of $2.09.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.